Clinical Evaluation of the Efficacy and Tolerability of Rigenase(®) and Polyhexanide (Fitostimoline(®) Plus) vs. Hyaluronic Acid and Silver Sulfadiazine (Connettivina(®) Bio Plus) for the Treatment of Acute Skin Wounds: A Randomized Trial

Objectives: Compare the efficacy and tolerability of Connettivina(®) Bio Plus (Group A) gauze and cream, and Fitostimoline(®) Plus (Group B) gauze and cream for the treatment of acute superficial skin lesions. Design: Single-center, parallel, randomized trial. A block randomization method was used. Setting: University of Salerno—AOU San Giovanni di Dio e Ruggi d’Aragona. Participants: Sixty patients were enrolled. All patients fulfilled the study requirements. Intervention: One application of the study drugs every 24 h, and a six-week observation period. Main outcome measures: Efficacy and tolerability of the study drugs. Results: In total, 60 patients (Group A, n = 30; Group B, n = 30) were randomized; mean age was 58.5 ± 15.8 years. All patients were included in the outcome analysis. Total wound healing was achieved in 17 patients undergoing treatment with Connettivina(®) Bio Plus and 28 patients undergoing treatment with Fitostimoline(®) Plus. The greater effectiveness of the latter was significant (p = 0.00104). In Group B, a significantly greater degree of effectiveness was observed in reducing the fibrin in the wound bed (p = 0.04746). Complications or unexpected events were not observed. Conclusions: Both Connettivina(®) Bio Plus and Fitostimoline(®) Plus are secure and effective for treating acute superficial skin lesions. Fitostimoline(®) Plus was more effective than Connettivina(®) Bio Plus in wound healing of acute superficial skin lesions, especially if fibrin had been observed in the wound bed.